# Maxime Dougados

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/maxime-dougados-2/

## Facts

| Field | Value |
| --- | --- |
| Citations | 48,463 |
| Field | Rheumatoid Arthritis Research and Therapies |
| h-index | 101 |
| i10-index | 319 |
| Last Known Institution | Délégation Paris 5 |
| OpenAlex ID | https://openalex.org/A5108092302 |
| Works | 631 |

## Researcher papers

- [2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis](https://scholariq.org/papers/2012-update-of-the-2008-american-college-of-rheumatology-recommendations-for-the/)
- [Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: Results of a multicenter, randomized, double‐blind, placebo‐controlled, phase III trial evaluating primary efficacy and safety at twenty‐four weeks](https://scholariq.org/papers/rituximab-for-rheumatoid-arthritis-refractory-to-anti-tumor-necrosis-factor/)
- [Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force](https://scholariq.org/papers/treating-rheumatoid-arthritis-to-target-2014-update-of-the-recommendations-of-an/)
- [Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis](https://scholariq.org/papers/development-of-an-asas-endorsed-disease-activity-score-asdas-in-patients-with/)
- [2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis](https://scholariq.org/papers/2010-update-of-the-asas-eular-recommendations-for-the-management-of-ankylosing/)
- [The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal](https://scholariq.org/papers/the-development-of-assessment-of-spondyloarthritis-international-society/)
- [European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update](https://scholariq.org/papers/european-league-against-rheumatism-eular-recommendations-for-the-management-of/)
- [Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative](https://scholariq.org/papers/multinational-evidence-based-recommendations-for-the-use-of-methotrexate-in/)
- [The DESIR cohort: A 10-year follow-up of early inflammatory back pain in France: Study design and baseline characteristics of the 708 recruited patients](https://scholariq.org/papers/the-desir-cohort-a-10-year-follow-up-of-early-inflammatory-back-pain-in-france/)

## Researcher topics

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Osteoarthritis Treatment and Mechanisms](https://scholariq.org/topics/osteoarthritis-treatment-and-mechanisms/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Autoimmune and Inflammatory Disorders Research](https://scholariq.org/topics/autoimmune-and-inflammatory-disorders-research/)

## Researcher university

- [Délégation Paris 5](https://scholariq.org/institutions/delegation-paris-5/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.